Patent ID: 7012099
Filing Date: 2006-03-14
Classification: A61K,A61P

Abstract:
1. A method for regulating the ORL1 receptor of the nociception/orphanin FQ ligand-ORL1 receptor system, comprising: administering a pharmaceutical composition comprising at least one substituted 4-amino-1-phenylbutan-2-ol compound of formula I wherein the radical A represents substituted or unsubstituted phenyl, the radicals R the radicals R the radicals R in the form of a racemate, an enantiomer, a diastereomer, base, or salt of a physiologically tolerable acid, and pharmaceuticallyu acceptable acceptable diluent or carrier to a human in need of regulation of the ORL1receptor of the nociceptin/orphanin FQ ligand-ORL1 receptor system for the treatment of anxiolysis.